Bank of New York Mellon’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $52.6K | Buy |
|
|||||
|
2025
Q2 | $16.1K | Sell |
|
|||||
|
2025
Q1 | $153K | Hold |
|
|||||
|
2024
Q4 | $170K | Buy |
|
|||||
|
2024
Q3 | $306K | Sell |
|
|||||
|
2024
Q2 | $435K | Buy |
|
|||||
|
2024
Q1 | $475K | Sell |
|
|||||
|
2023
Q4 | $390K | Buy |
|
|||||
|
2023
Q3 | $421K | Hold |
|
|||||
|
2023
Q2 | $503K | Buy |
|
|||||
|
2023
Q1 | $106K | Hold |
|
|||||
|
2022
Q4 | $82.9K | Buy |
|
|||||
|
2022
Q3 | $80K | Hold |
|
|||||
|
2022
Q2 | $112K | Sell |
|
|||||
|
2022
Q1 | $633K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Sell |
|
|||||
|
2021
Q3 | $1.07M | Buy |
|
|||||
|
2021
Q2 | $1.09M | Buy |
|
|||||
|
2021
Q1 | $171K | Sell |
|
|||||
|
2020
Q4 | $144K | Buy |
|
|||||
|
2020
Q3 | $74K | Hold |
|
|||||
|
2020
Q2 | $69K | Sell |
|
|||||
|
2020
Q1 | $340K | Sell |
|
|||||
|
2019
Q4 | $441K | Buy |
|
|||||
|
2019
Q3 | $447K | Buy |
|
|||||
|
2019
Q2 | $449K | Sell |
|
|||||
|
2019
Q1 | $616K | Buy |
|
|||||
|
2018
Q4 | $373K | Sell |
|
|||||
|
2018
Q3 | $1.8M | Buy |
|
|||||
|
2018
Q2 | $1.53M | Buy |
|
|||||
|
2018
Q1 | $1.91M | Buy |
|
|||||
|
2017
Q4 | $1.42M | Buy |
|
|||||
|
2017
Q3 | $1.31M | Sell |
|
|||||
|
2017
Q2 | $1.5M | Buy |
|
|||||
|
2017
Q1 | $1.53M | Buy |
|
|||||
|
2016
Q4 | $1.37M | Buy |
|
|||||
|
2016
Q3 | $999K | Buy |
|
|||||
|
2016
Q2 | $628K | Buy |
|
|||||
|
2016
Q1 | $601K | Sell |
|
|||||
|
2015
Q4 | $887K | Buy |
|
|||||
|
2015
Q3 | $603K | Sell |
|
|||||
|
2015
Q2 | $871K | Buy |
|
|||||
|
2015
Q1 | $1.01M | Sell |
|
|||||
|
2014
Q4 | $800K | Buy |
|
|||||
|
2014
Q3 | $579K | Buy |
|
|||||
|
2014
Q2 | $557K | Buy |
|
|||||
|
2014
Q1 | $543K | Sell |
|
|||||
|
2013
Q4 | $600K | Buy |
|
|||||
|
2013
Q3 | $610K | Sell |
|
|||||
|
2013
Q2 | $638K | Buy |
|